Shopping Cart
Remove All
Your shopping cart is currently empty
Sphingolactone-24 (50 µM; 30 min+24 h) inhibits p38 MAPK phosphorylation induced by LPS and counters its anti-apoptotic effects.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,670 | 8-10 weeks | 8-10 weeks | |
| 50 mg | $2,180 | 8-10 weeks | 8-10 weeks | |
| 100 mg | $2,800 | 8-10 weeks | 8-10 weeks |
| Description | Sphingolactone-24 (50 µM; 30 min+24 h) inhibits p38 MAPK phosphorylation induced by LPS and counters its anti-apoptotic effects. |
| In vitro | Sphingolactone-24 (50 µM; 30 min+24 h) inhibits p38 MAPK phosphorylation induced by LPS and counters its anti-apoptotic effects. |
| In vivo | Sphingolactone-24, administered at a dose of 1 mg/kg intraperitoneally at 3 and 9 hours post LPS exposure, mitigates the severity of LPS-induced acute lung injury (ALI) and enhances survival rates in mice subjected to pulmonary damage due to LPS. In this study, the animal model utilized was C3H/HeN breeder mice, which received LPS at 10 mg/kg via intranasal instillation. The treatment not only improved survival but also significantly reduced the severity of ALI. |
| Synonyms | Sph-24 |
| Molecular Weight | 323.43 |
| Formula | C18H29NO4 |
| Cas No. | 881177-99-7 |
| Smiles | [C@H](NC(/C=C/C=C/C)=O)(CO)[C@]1(CC(CCCCCC)C(=O)O1)[H] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.